NCT02359513View on ClinicalTrials.gov

Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 9, 2015

Primary Completion Date

November 12, 2021

Study Completion Date

March 11, 2022

Conditions
Bulimia Nervosa
Interventions
DRUG

Antidepressants

bulimic patients are treated during 3 months

DRUG

Positron Emission Tomography (PET)

PET scan using \[18F\]MPPF is performed before and after (3 months)antidepressant treatment

Trial Locations (4)

38043

CHU Grenoble, Grenoble

42055

Chu Saint-Etienne, Saint-Etienne

69678

Groupement Hospitalier Est - HCL, Bron

Unknown

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02359513 - Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. | Biotech Hunter | Biotech Hunter